Royal Bank of Canada’s Fulgent Genetics FLGT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $11K | Sell |
728
-573
| -44% | -$12.4K | ﹤0.01% | 6123 |
|
|
2025
Q4 | $35K | Buy |
1,301
+70
| +6% | +$1.82K | ﹤0.01% | 5737 |
|
|
2025
Q3 | $28K | Sell |
1,231
-1,456
| -54% | -$30K | ﹤0.01% | 6066 |
|
|
2025
Q2 | $54K | Buy |
2,687
+124
| +5% | +$2.42K | ﹤0.01% | 5890 |
|
|
2025
Q1 | $43K | Sell |
2,563
-800
| -24% | -$13.6K | ﹤0.01% | 5628 |
|
|
2024
Q4 | $62K | Buy |
3,363
+356
| +12% | +$6.95K | ﹤0.01% | 5584 |
|
|
2024
Q3 | $66K | Sell |
3,007
-1,612
| -35% | -$36K | ﹤0.01% | 5569 |
|
|
2024
Q2 | $91K | Buy |
4,619
+2,984
| +183% | +$62.3K | ﹤0.01% | 5318 |
|
|
2024
Q1 | $35K | Sell |
1,635
-10,473
| -86% | -$260K | ﹤0.01% | 5684 |
|
|
2023
Q4 | $350K | Buy |
12,108
+2,170
| +22% | +$58.1K | ﹤0.01% | 4592 |
|
|
2023
Q3 | $266K | Sell |
9,938
-1,322
| -12% | -$45.1K | ﹤0.01% | 4544 |
|
|
2023
Q2 | $418K | Buy |
11,260
+3,331
| +42% | +$116K | ﹤0.01% | 4086 |
|
|
2023
Q1 | $248K | Sell |
7,929
-727
| -8% | -$23.4K | ﹤0.01% | 4437 |
|
|
2022
Q4 | $257K | Buy |
8,656
+932
| +12% | +$33.4K | ﹤0.01% | 4665 |
|
|
2022
Q3 | $294K | Sell |
7,724
-1,425
| -16% | -$71.4K | ﹤0.01% | 4451 |
|
|
2022
Q2 | $499K | Sell |
9,149
-2,784
| -23% | -$153K | ﹤0.01% | 4099 |
|
|
2022
Q1 | $745K | Sell |
11,933
-7,895
| -40% | -$520K | ﹤0.01% | 3918 |
|
|
2021
Q4 | $2M | Sell |
19,828
-7,541
| -28% | -$663K | ﹤0.01% | 3158 |
|
|
2021
Q3 | $2.46M | Sell |
27,369
-446
| -2% | -$40.5K | ﹤0.01% | 2900 |
|
|
2021
Q2 | $2.56M | Buy |
27,815
+14,869
| +115% | +$1.19M | ﹤0.01% | 2848 |
|
|
2021
Q1 | $1.25M | Sell |
12,946
-4,782
| -27% | -$494K | ﹤0.01% | 3386 |
|
|
2020
Q4 | $923K | Sell |
17,728
-6,286
| -26% | -$263K | ﹤0.01% | 3543 |
|
|
2020
Q3 | $962K | Buy |
24,014
+2,163
| +10% | +$67.7K | ﹤0.01% | 3288 |
|
|
2020
Q2 | $350K | Buy |
21,851
+21,606
| +8,819% | +$331K | ﹤0.01% | 4053 |
|
|
2020
Q1 | $3K | Sell |
245
-8,799
| -97% | -$123K | ﹤0.01% | 6184 |
|
|
2019
Q4 | $117K | Buy |
9,044
+8,891
| +5,811% | +$106K | ﹤0.01% | 5001 |
|
|
2019
Q3 | $2K | Buy |
+153
| New | +$1.45K | ﹤0.01% | 6278 |
|
|
2019
Q1 | – | Sell |
-13
| Closed | – | – | 6904 |
|
|
2018
Q4 | $0 | Hold |
13
| – | – | ﹤0.01% | 6868 |
|
|
2018
Q3 | $0 | Buy |
+13
| New | +$56 | ﹤0.01% | 6789 |
|
|
2018
Q2 | – | Sell |
-300
| Closed | -$1K | – | 6594 |
|
|
2018
Q1 | $1K | Sell |
300
-1
| -0.3% | -$4 | ﹤0.01% | 6198 |
|
|
2017
Q4 | $1K | Hold |
301
| – | – | ﹤0.01% | 6381 |
|
|
2017
Q3 | $1K | Buy |
+301
| New | +$1.73K | ﹤0.01% | 6622 |
|
|
2017
Q2 | – | Sell |
-218
| Closed | -$3K | – | 6621 |
|
|
2017
Q1 | $3K | Sell |
218
-609
| -74% | -$7.2K | ﹤0.01% | 6347 |
|
|
2016
Q4 | $10K | Buy |
+827
| New | +$7.8K | ﹤0.01% | 6078 |
|
Other funds holding FLGT
RI
VCM
ICM
Royal Bank of Canada's FLGT Position: Q1 2026 in Review
Royal Bank of Canada reduced its Fulgent Genetics (FLGT) stake by 44% in Q1 2026, selling an estimated $12.4K and leaving 728 shares worth $11K. The position accounts for ﹤0.01% of the portfolio, ranked #6123.
Royal Bank of Canada first reported a position in FLGT in Q4 2016 and has held it in 34 quarters since. The position peaked at $2.56M in Q2 2021. 157 funds tracked by Wall St. Rank hold FLGT as of Q1 2026.
- Royal Bank of Canada held 728 shares of Fulgent Genetics worth $11K as of Q1 2026.
- Royal Bank of Canada sold 573 Fulgent Genetics shares in Q1 2026, an estimated $12.4K.
- Fulgent Genetics made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #6123 holding.
- Royal Bank of Canada first reported a position in Fulgent Genetics in Q4 2016 and has held it in 34 quarters since.
- Royal Bank of Canada's Fulgent Genetics position peaked at $2.56M in Q2 2021.
- 157 funds tracked by Wall St. Rank held Fulgent Genetics as of Q1 2026.
Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.